Scientific Publications

Business Opportunities


Education & Training

Biological Safety

Unified Culture Collection

Special Pathogens Lab

Reference Materials

Related Links


Contact Us


>>  Home  >>  Newsroom

Featured Articles Media

— News Releases —

— 2023 —

Former Soldier Named Civilian of the Quarter at Army's Infectious Disease Research Institute
  (May 15, 2023)

USAMRIID Chief Information Officer, Dale Angleberger, Retires after 34 Years
  (May 8, 2023)

USAMRIID Takes Top Honors in USAMRDC Best Squad Competition External Link
  (April 19, 2023)

Teamwork Key to Success for Army Lab's 2022 Employee of the Year
  (March 28, 2023)

USAMRIID Scientist Arthur M. Friedlander Elected to American Academy of Microbiology
  (March 7, 2023)

From Scientist to Soldier: Researcher Fulfills Lifelong Dream in Joining U.S. Army Reserve
  (February 14, 2023)

Dr. Sara Ruiz Named USAMRIID Civilian of the Quarter
  (February 13, 2023)

Dr. Joel Bozue Named USAMRIID Civilian of the Quarter
  (January 11, 2023)

USAMRIID Focuses on Genome Sequencing to Detect Variants External Link
  (January 5, 2023)

— 2022 —

U.S. Army medical team helps Smithsonian National Zoo to protect endangered Red Pandas External Link
  (December 13, 2022)

Researchers Detect Monkeypox Virus in Testes of Nonhuman Primate Survivors
  (October 17, 2022)

Messenger RNA Technology Could Be Used to Develop Infectious Disease Therapeutics
  (July 7, 2022)

Soldier finds success, citizenship in US Army External Link
  (May 31, 2022)

Research Sheds Light on Crimean-Congo Hemorrhagic Fever Disease Process
  (May 20, 2022)

Antibody Shows Promise for Developing Hantavirus Treatment
  (March 21, 2022)

USAMRIID Scientist Wins AMSUS Research and Development Award
  (February 24, 2022)

Study Reveals Ebola Virus Can Hide in Brain, Persist Even After Treatment
  (February 9, 2022)

Scientists Develop First Lethal Hamster Model for COVID-19
  (January 25, 2022)

— 2021 —

Experimental Treatment with Enzyme Protects Mice from Lethal Anthrax Infection
  (December 8, 2021)

USAMRIID Soldiers Recognized for Operation Warp Speed Support
  (August 12, 2021)

Gene Sequencing Tools Pinpoint Origins of Bundibugyo Virus Disease Outbreak
  (July 28, 2021)

Scientists Develop Novel Therapy for Crimean-Congo Hemorrhagic Fever Virus
  (June 1, 2021)

Scientists Establish Multiple Primate Models of SARS-CoV-2 Airborne Infection
  (February 4, 2021)

— 2020 —

Outbreak Investigation Reveals "Super-Spreader" Potential of Andes Virus
  (December 3, 2020)

USAMRIID Scientist Receives Medal of Honor from French Military
  (November 19, 2020)

Scientists Establish First Lethal Mouse Model for COVID-19
  (August 27, 2020)

Army and Illinois Researchers Design, Test Protein that May Lead to COVID-19 Therapeutic
  (August 14, 2020)

First-Ever Experimental Sudan Virus Specific Antibody Treatment Protects Animals
  (February 3, 2020)

— 2019 —

New Smallpox Vaccine Tested by USAMRIID Receives FDA Approval
  (September 30, 2019)

USAMRIID Officer Retires After 30 Years of Military Service
  (September 19, 2019)

USAMRIID Research Provides Regulatory Framework for Developing Ebola Virus Therapeutic under FDA "Animal Rule"
  (March 28, 2019)

Experimental Antibody "Cocktail" Protects Animals from Three Deadly Ebola Viruses
  (January 10, 2019)

— 2018 —

USAMRIID Scientists Help Identify Key Hantavirus Receptor
  (November 21, 2018)

Mechanism of Marburg Virus Sexual Transmission Identified in Nonhuman Primates
  (August 30, 2018)

Study of Bat Natural Immunity to Marburg Virus May Shed Light on Human Disease
  (April 26, 2018)

Potential Biomarkers in Animals Could Signal Ebola Virus Infection Before Symptoms Appear
  (March 28, 2018)

Smallpox Vaccine Study Yields Favorable Results: Research Paves Way for Replacing Current U.S. Licensed Vaccine
  (February 7, 2018)

Genetic Sequencing Points to Endemic Origin of Monkeypox Virus Outbreak in Nigeria
  (January 18, 2018)

— 2017 —

Tasso, Ceres Nanosciences, George Mason University, and the United States Army Medical Research Institute of Infectious Diseases receive $4.25M to develop a universal surveillance platform for infectious disease outbreaks.
  (September 28, 2017)

PET Imaging Tracks Zika Virus Infection, Disease Progression in Mouse Model
  (September 19, 2017)

Ebola Virus Can Persist in Monkeys that Survived Disease, Even After Symptoms Disappear
  (July 17, 2017)

Near Real-Time Genomic Sequencing Maps Introduction and Spread of Zika Virus in U.S.
  (May 24, 2017)

— 2016 —

New 'Trojan Horse' Antibody Strategy Shows Promise Against All Ebola Viruses
  (September 8, 2016)

Newly Discovered "Multicomponent" Virus Can Infect Animals
  (August 25, 2016)

Anthrax Capsule Vaccine Completely Protects Monkeys from Lethal Inhalational Anthrax
  (June 27, 2016)

Ebola Virus Genome Provides Clues to Repeated Disease "Flare-Ups" in Western Africa
  (April 29, 2016)

USAMRIID Receives Technology Transfer Award for Experimental Ebola Treatment
  (April 28, 2016)

Novel Small-Molecule Antiviral Compound Protects Monkeys from Deadly Ebola Virus
  (March 3, 2016)

Single Antibody From Human Survivor Protects Nonhuman Primates Against Ebola Virus
  (February 25, 2016)

— 2015 —

Genomic Analysis Sheds Light on Ebola Virus Disease Outbreak in Liberia
  (December 9, 2015)

Sexual Transmission of Ebola Virus in Liberia Confirmed Using Genomic Analysis
  (October 15, 2015)

Antiviral Compound Provides Full Protection from Ebola Virus in Nonhuman Primates
  (October 9, 2015)

Ebola Virus Mutations May Help It Evade Drug Treatment
  (September 11, 2015)

Antiviral Compound Protects Nonhuman Primates against Marburg Virus:  Safety Profile Also Evaluated in Phase I Clinical Trial
  (July 22, 2015)

Study Identifies Ebola Virus's Achilles' Heel
  (May 26, 2015)

Genomics Laboratory Capability in Liberia Supports Ebola Virus Outbreak Response
  (May 14, 2015)

Antiviral Compound Protects Nonhuman Primates Against Ebola Virus
  (February 10, 2015)

Genetic Changes in Ebola Virus Could Impede Potential Treatments
  (January 20, 2015)

— 2014 —

Human Antibodies Produced in DNA-Vaccinated Cows Protect in Lethal Models of Hantavirus Pulmonary Syndrome
  (November 26, 2014)

Sierra Leone Samples: Ebola Evidence in West Africa in 2006
  (July 14, 2014)

USAMRIID Research Sheds Light on How Deadly Lassa Virus Infects Cells
  (June 27, 2014)

Army Leads Collaborative Effort to Establish Standards for Sequencing Viral Genomes
  (June 25, 2014)

Novel Drug Treatment Protects Primates from Deadly Marburg Virus
  (March 3, 2014)

— 2013 —

USAMRIID Scientist Wins Department of Defense's Highest Civilian Honor
  (November 18, 2013)

USAMRIID Deputy Commander to Receive 2013 Trailblazer Award at MD Women's Conference
  (October 15, 2013)

USAMRIID Clinical Laboratory Passes CAP Accreditation Survey with Zero Deficiencies
  (August 27, 2013)

Experimental Ebola Treatment Protects Some Primates Even After Disease Symptoms Appear
  (August 21, 2013)

— 2012 —

Ebola Antibody Treatment, Produced in Plants, Protects Monkeys from Lethal Disease
  (October 15, 2012)

Army Study:  DNA Vaccine and Duck Eggs Protect Against Hantavirus Disease
  (May 23, 2012)

Army Scientist Nominated for 2012 Service to America Medal
  (May 8, 2012)

Post-Exposure Antibody Treatment Protects Primates from Ebola, Marburg Viruses
  (March 13, 2012)

Anthrax Capsule Vaccine Protects Monkeys from Lethal Infection
  (January 12, 2012)

— 2011 —

Single Protein, Key to Ebola Virus Infection, Could Aid in Drug Design
  (August 24, 2011)

USAMRIID Begins Clinical Trial of New Vaccine to Protect Against Ricin Toxin
  (April 13, 2011)

— 2010 —

Novel "Antisense" Therapies Protect Primates from Lethal Ebola and Marburg Viruses
  (August 22, 2010)

PDF file Overcoming Anthrax Bacterium's Natural Defenses Could Hold Key to New Treatment
  (May 18, 2010)

— 2009 —

Update on USAMRIID Scientist with Tularemia
  (December 9, 2009)

USAMRIID Scientist Appears to be Ill with Tularemia
  (December 4, 2009)

Single Host Gene May Hold Key to Treating Both Ebola and Anthrax Infections
  (August 20, 2009)

— 2008 —

USAMRIID Scientist Leonard A. Smith Selected for Unique Leadership Position
  (June 19, 2008)

USAMRIID's Next Generation Anthrax Vaccine Acquired for Advanced Development
  (May 12, 2008)

Hopkins Biotech Program Enters Collaborative Relationship with USAMRIID
  (May 9, 2008)

Scientists Determine Drug Target for the Most Potent Botulinum Neurotoxin
  (April 29, 2008)

— 2007 —

USAMRIID Scientist Named to List of Ten Outstanding Young Americans
  (September 20, 2007)

— 2006 —

Vaccine Combined with Short-Term Postexposure Antibiotics Protects Monkeys from Inhalational Anthrax
  (May 1, 2006)

Experimental Vaccine Protects Nonhuman Primates When Given after Exposure to Marburg Virus
  (April 26, 2006)

Environmental Impact Statement Planned for USAMRIID Facilities at Fort Detrick
  (February 8, 2006)

Gene-Specific Ebola Therapies Protect Nonhuman Primates from Lethal Disease
  (January 13, 2006)

— 2005 —

Anthrax Test, Developed by Army and CDC, Receives FDA Approval
  (August 30, 2005)

Experimental Vaccine Protects Nonhuman Primates from Lassa Fever
  (June 27, 2005)

Researchers Report Breakthrough Against World's Deadliest Viruses
  (June 5, 2005)

Comprehensive Biodefense Text Published
  (May 18, 2005)

— 2004 —

Vaccination with Anthrax Capsule Protects Against Experimental Infection in Animals
  (December 1, 2004)

Research Team Develops Nonhuman Primate Model of Smallpox Infection
  (October 5, 2004)

Managing Occupational Exposures to Potential Bioterrorist Agents
  (August 20, 2004)

Protein Vaccine Fully Protects Mice from Lethal Aerosol Challenge with Ricin Toxin
  (August 4, 2004)

Fort Detrick Scientist Receives Bronze Star Medal for Iraq Service
  (June 24, 2004)

Experimental Smallpox DNA Vaccine Protects Primates from Lethal Monkeypox
  (April 27, 2004)

Experimental Smallpox Vaccine Protects against Monkeypox in Nonhuman Primates
  (March 10, 2004)

USAMRIID Scientist Peter B. Jahrling Elected Fellow by AAAS
  (February 12, 2004)

Smallpox in 50-Year-Old Tissues Detected by Integrated Diagnostics Approach
  (January 29, 2004)

Small-Molecule Inhibitors of Anthrax Lethal Factor Identified
  (January 22, 2004)

— 2003 —

Drug Shows Promise for Ebola Virus Treatment in Primates
  (December 11, 2003)

Ebola Virus-Like Particles Protect Mice from Lethal Ebola Virus Infection
  (December 9, 2003)

Small-Molecule Inhibitors of Botulinum Neurotoxin Identified
  (November 12, 2003)

Experimental Hantavirus Vaccine Elicits Strong Antibody Response in Primates
  (October 23, 2003)

Documents on this page are PDF files .  In order to view these PDF documents, you must have Adobe Acrobat Reader.  If you already have this program, you may begin browsing the documents.  If you do not have this program, go to Get Adobe Acrobat Reader.